384 related articles for article (PubMed ID: 14742274)
1. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice.
Hoyte K; Jayasinha V; Xia B; Martin PT
Am J Pathol; 2004 Feb; 164(2):711-8. PubMed ID: 14742274
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016
[TBL] [Abstract][Full Text] [Related]
3. Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy.
Culligan K; Glover L; Dowling P; Ohlendieck K
BMC Cell Biol; 2001; 2():2. PubMed ID: 11178104
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
[TBL] [Abstract][Full Text] [Related]
6. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.
Schofield JN; Górecki DC; Blake DJ; Davies K; Edwards YH
Dev Dyn; 1995 Oct; 204(2):178-85. PubMed ID: 8589441
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
8. Evolution of pathological changes in the gastrocnemius of the mdx mice correlate with utrophin and beta-dystroglycan expression.
Roma J; Munell F; Fargas A; Roig M
Acta Neuropathol; 2004 Nov; 108(5):443-52. PubMed ID: 15365724
[TBL] [Abstract][Full Text] [Related]
9. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin.
Montanaro F; Carbonetto S; Campbell KP; Lindenbaum M
J Neurosci Res; 1995 Nov; 42(4):528-38. PubMed ID: 8568939
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle.
Fujimori K; Itoh Y; Yamamoto K; Miyagoe-Suzuki Y; Yuasa K; Yoshizaki K; Yamamoto H; Takeda S
Hum Gene Ther; 2002 Mar; 13(4):509-18. PubMed ID: 11874629
[TBL] [Abstract][Full Text] [Related]
11. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
12. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
Dowling P; Lohan J; Ohlendieck K
Eur J Cell Biol; 2003 May; 82(5):222-30. PubMed ID: 12800977
[TBL] [Abstract][Full Text] [Related]
14. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
15. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins.
Moghadaszadeh B; Albrechtsen R; Guo LT; Zaik M; Kawaguchi N; Borup RH; Kronqvist P; Schroder HD; Davies KE; Voit T; Nielsen FC; Engvall E; Wewer UM
Hum Mol Genet; 2003 Oct; 12(19):2467-79. PubMed ID: 12915458
[TBL] [Abstract][Full Text] [Related]
16. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
[TBL] [Abstract][Full Text] [Related]
17. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
Jayasinha V; Nguyen HH; Xia B; Kammesheidt A; Hoyte K; Martin PT
Neuromuscul Disord; 2003 Jun; 13(5):365-75. PubMed ID: 12798792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]